Tarsus to Participate in Upcoming Investor Conferences
Tarsus Pharmaceuticals (NASDAQ: TARS) announced its participation in three upcoming investor conferences. Executives will join fireside chats at the William Blair Growth Stock Conference on June 4, 2024, the Jefferies Global Healthcare Conference on June 5, 2024, and the Goldman Sachs Global Healthcare Conference on June 10, 2024. Attendees include Jeff Farrow, Chief Financial and Chief Strategy Officer, Aziz Mottiwala, Chief Commercial Officer, and Bobak Azamian, CEO and Chairman. Live webcasts will be accessible on Tarsus's website, with replays available within 48 hours.
- Participation in high-profile investor conferences enhances visibility.
- Involvement of top executives like the CEO, CFO, and Chief Commercial Officer adds credibility.
- Opportunity to communicate strategic vision and developments directly to investors.
- No new financial or clinical data disclosed, limiting immediate investor insights.
- Potential high costs associated with attending multiple high-profile conferences.
IRVINE, Calif., May 29, 2024 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting with eye care, today announced that management will participate in the following conferences:
- William Blair Growth Stock Conference
- Jeff Farrow, Chief Financial and Chief Strategy Officer, will participate in an in-person fireside chat on Tuesday, June 4, 2024, at 1:20 p.m. PT / 4:20 p.m. ET
- Jefferies Global Healthcare Conference
- Jeff Farrow, Chief Financial and Chief Strategy Officer, and Aziz Mottiwala, Chief Commercial Officer, will participate in an in-person fireside chat on Wednesday, June 5, 2024, at 12 p.m. PT / 3 p.m. ET
- Goldman Sachs Global Healthcare Conference
- Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman, and Jeff Farrow, Chief Financial and Chief Strategy Officer, will participate in an in-person fireside chat on Monday, June 10, 2024, at 11 a.m. PT / 2 p.m. ET
Live webcasts and additional information about the webcasts can be accessed on the events section of the Tarsus website. Replays of the webcasts will be available on the Tarsus website within 48 hours and will be archived for a limited time.
About Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc. applies proven science and new technology to revolutionize treatment for patients, starting with eye care. Tarsus is advancing its pipeline to address several diseases with high unmet need across a range of therapeutic categories, including eye care, dermatology and infectious disease prevention. XDEMVY® (lotilaner ophthalmic solution)
Contacts:
Media Contact:
Adrienne Kemp
Sr. Director, Corporate Communications
(949) 922-0801
akemp@tarsusrx.com
Investor Contact:
David Nakasone
Head of Investor Relations
(949) 620-3223
DNakasone@tarsusrx.com
FAQ
When will Tarsus participate in the William Blair Growth Stock Conference?
Which executives from Tarsus will attend the Jefferies Global Healthcare Conference?
What is the date of Tarsus's fireside chat at the Goldman Sachs Global Healthcare Conference?
Where can I find the webcasts of Tarsus's investor conference participation?
What is the stock symbol for Tarsus Pharmaceuticals?
